ProUroCare Medical Inc.

PUMD

US74373C2061

Advanced Medical Equipment & Technology

Delayed OTC Markets Other stock markets 03:38:07 2023-10-23 pm EDT			5-day change	1st Jan Change
0.0001 ^USD	-.--%		-.--%	-.--%

2014	ProUroCare Medical Inc. Announces Resignation of Robert Rudelius from the Board of Directors	CI
2013	ProUroCare Medical Inc. announced that it expects to receive $0.50 million in funding.	CI

ProUroCare Medical Inc. announced that it expects to receive $2 million in funding.

February 31, 2012 at 11:00 pm EST

ProUroCare Medical Inc. (OTCBB:PUMD) announced a private placement of convertible notes for gross proceeds of $2,000,000 on February 1, 2012. The securities will be issued pursuant to Regulation D.

Latest news about ProUroCare Medical Inc.

ProUroCare Medical Inc. Announces Resignation of Robert Rudelius from the Board of Directors	14-02-12	CI
ProUroCare Medical Inc. announced that it expects to receive $0.50 million in funding.	13-10-16	CI
ProUroCare Medical Inc. Appoints David Kaysen as a Member of Board of Directors	13-09-10	CI
ProUroCare Medical Inc. Announces Executive Changes	13-05-22	CI
ProUroCare Medical Inc. Announces Management Changes	13-04-19	CI
ProUroCare Medical Inc. Refinances its $500,000 Promissory Note with Crown Bank; Announces the Resignation of David Barrett as Director	13-03-28	CI
ProUroCare Medical Inc. Appoints Doris Engibous as Interim Chief Operating Officer	12-12-13	CI
ProUroCare Medical Inc. Amends the Maturity Date of its $900,000 Promissory Note with Crown Bank; Announces Management Changes	12-11-30	CI
ProUroCare Medical Inc. Announces Board Changes	12-11-05	CI
ProUroCare Medical Inc. announced that it has received $0.25 million in funding.	12-10-29	CI
ProUroCare Medical Inc. announced that it has received $0.15 million in funding.	12-09-26	CI
ProUroCare Medical Inc. Appoints Stan Myrum to Head Technology and Product Development Activities	12-08-06	CI
ProUroCare Medical Inc. announced that it has received $0.71 million in funding.	12-07-02	CI
ProUroCare Medical Inc. Receives Clearance from the U.S. Food & Drug Administration for its ProUroScan(TM) Prostate Mechanical Imaging System	12-05-01	CI
ProUroCare Medical Seeks Partner	12-05-01	CI
ProUroCare Medical Inc. announced that it expects to receive $1 million in funding.	12-04-12	CI
ProUroCare Medical Inc. announced that it expects to receive $2 million in funding.	12-01-31	CI

ProUroCare Medical Inc. (ProUroCare) is engaged in the business of developing products for the detection and characterization of prostate disease. The Company is focused on its product, prostate mechanical imaging device called the ProUroScan System. The ProUroScan is an imaging system that is designed to produce an elasticity image of the prostate as an adjunctive aid in visualizing and documenting abnormalities of the prostate that have been detected by a digital rectal examination (DRE). The ProUroScan uses an array of sensors mounted on a rectal probe, a central processing unit, and software and image construction algorithms to provide a real time color image of abnormalities in the prostate. In addition, it provides mechanical or elasticity imaging, which refers to a non-invasive analysis of tissue movement and displacement. The Companyâs product also provides two-and three-dimensional prostate images.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Medical Imaging Systems

	1st Jan change	Capi.
PROUROCARE MEDICAL INC.	-.--%	1.86K
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-7.36%	14.67B
IRAY TECHNOLOGY COMPANY LIMITED	-36.98%	2.85B
SONOSCAPE MEDICAL CORP.	-11.25%	2.51B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-14.58%	1.42B
CORETAG, INC.	-.--%	1.12B
NANO-X IMAGING LTD.	+55.73%	566M
GUERBET	+89.49%	507M
DETECTION TECHNOLOGY OYJ	+25.91%	269M
DRTECH CORPORATION	-8.57%	221M

Medical Imaging Systems